© All rights reserved to Barnea Jaffa Lande Law offices

Together is global

Regulation / Healthcare Regulatory

Life-science companies, whether global corporations or startups, are forced to operate in a highly regulated industry. This often creates complex legal challenges.

Improper application of regulatory requirements may prolong a company’s product’s go-to-market, thereby affecting both return on investment and patient health. It may also have legal implications.

 

Understanding the importance of regulation, Barnea strives to provide comprehensive legal regulatory services to Israeli and foreign companies operating in the healthcare field. We represent clients working in biotechnology, medical instrumentation, pharmaceuticals, diagnostic instrumentation, imaging, and more.

 

Our counsel covers both legal and regulatory issues, including intellectual property, privacy, and consumer protection. We also advise clients in the process of adjusting and assimilating changes to regulatory requirements.

 

We offer companies services that span across R&D, product registration, licensing and grant applications, and distribution and marketing.

 

Back to Regulation

Insights & News - Regulation / Healthcare Regulatory:


October 2, 2022

Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog

September 8, 2022

Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million

May 22, 2022

BioGenCell Completes USD 16 Million Seed Round

Regulation / Healthcare Regulatory

Life-science companies, whether global corporations or startups, are forced to operate in a highly regulated industry. This often creates complex legal challenges.

Improper application of regulatory requirements may prolong a company’s product’s go-to-market, thereby affecting both return on investment and patient health. It may also have legal implications.

 

Understanding the importance of regulation, Barnea strives to provide comprehensive legal regulatory services to Israeli and foreign companies operating in the healthcare field. We represent clients working in biotechnology, medical instrumentation, pharmaceuticals, diagnostic instrumentation, imaging, and more.

 

Our counsel covers both legal and regulatory issues, including intellectual property, privacy, and consumer protection. We also advise clients in the process of adjusting and assimilating changes to regulatory requirements.

 

We offer companies services that span across R&D, product registration, licensing and grant applications, and distribution and marketing.

 

Back to Regulation

Insights & News:


October 2, 2022

Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog

September 8, 2022

Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million

May 22, 2022

BioGenCell Completes USD 16 Million Seed Round